Keyword: Elaine Burridge

News

Omya Opens Laboratory in Switzerland

21.03.2016 - Swiss specialty chemicals producer and distributor Omya has opened a new pharmaceutical and nutraceutical laboratory at its headquarters in Oftringen, gaining the capability to...

News

Vectura Pays £441 Million for Skyepharma

18.03.2016 - UK drug maker Vectura is buying fellow biotechnology firm Skyepharma in a deal worth around £441 million ($637 million). The merger will create an industry leading specialist in...

News

Air Products and Evonik Close to Performance Materials Deal?

18.03.2016 - Air Products & Chemicals is in advanced talks to sell its performance materials business to Evonik Industries, news agencies have reported. A deal for the business, called Versum...

News

Blueprint and Roche in Cancer Immunotherapy Deal

17.03.2016 - US biotechnology company Blueprint Medicines is collaborating with Swiss drugs giant Roche on the discovery, development and commercialization of up to five cancer immunotherapies...

News

Solvay to Exit Ineos Chlorvinyls Early

17.03.2016 - Solvay has announced it will quit the Inovyn chlorvinyls joint venture with Ineos in the second half of 2015, more than two years earlier than anticipated, giving its Swiss-based...

News

Wanhua Starts Production of IPDI in China

16.03.2016 - China’s Wanhua Chemical Group has successfully started up its new aliphatic diisocyanate (ADI) plant in Yantai Industrial Park. The facility produces isophorone diisocyanate (IPDI)...

News

Dechra Buys US Animal Health Company Putney

16.03.2016 - The UK’s Dechra Pharmaceuticals is boosting its presence in the US animal health market with the proposed acquisition of Putney, a Portland, Maine-based developer of generic...

News

GSK Ends Cancer Deal With Five Prime

15.03.2016 - British drugmaker Glaxo SmithKline (GSK) has pulled out of a five-year deal with US biotechnology company Five Prime to develop experimental cancer drug FP-1039. Buried in Five...